Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
Implantable cardioverter defibrillators (ICDs) are the cornerstone of primary and secondary prevention of sudden cardiac death (SCD) all around the globe. In almost 40 years of technological advances and multiple clinical trials, there has been a continuous increase in the implantation rate. The pur...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-04-01
|
| Series: | Journal of Cardiovascular Development and Disease |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2308-3425/9/4/120 |
| _version_ | 1827628337857560576 |
|---|---|
| author | Andreea Maria Ursaru Antoniu Octavian Petris Irina Iuliana Costache Ana Nicolae Adrian Crisan Nicolae Dan Tesloianu |
| author_facet | Andreea Maria Ursaru Antoniu Octavian Petris Irina Iuliana Costache Ana Nicolae Adrian Crisan Nicolae Dan Tesloianu |
| author_sort | Andreea Maria Ursaru |
| collection | DOAJ |
| description | Implantable cardioverter defibrillators (ICDs) are the cornerstone of primary and secondary prevention of sudden cardiac death (SCD) all around the globe. In almost 40 years of technological advances and multiple clinical trials, there has been a continuous increase in the implantation rate. The purpose of this review is to highlight the grey areas related to actual ICD recommendations, focusing specifically on the primary prevention of SCD. We will discuss the still-existing controversies strongly reflected in the differences between the international guidelines regarding ICD indication class in non-ischemic cardiomyopathy, and also address the question of early implantation after myocardial infarction in the absence of clear protocols for patients at high risk of life-threatening arrhythmias. Correlating the insufficient data in the literature for 40-day waiting times with the increased risk of SCD in the first month after myocardial infarction, we review the pros and cons of early ICD implantation. |
| first_indexed | 2024-03-09T13:30:14Z |
| format | Article |
| id | doaj.art-7e9b2dec35c84cec8c94e4c4c0599fbd |
| institution | Directory Open Access Journal |
| issn | 2308-3425 |
| language | English |
| last_indexed | 2024-03-09T13:30:14Z |
| publishDate | 2022-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Cardiovascular Development and Disease |
| spelling | doaj.art-7e9b2dec35c84cec8c94e4c4c0599fbd2023-11-30T21:18:31ZengMDPI AGJournal of Cardiovascular Development and Disease2308-34252022-04-019412010.3390/jcdd9040120Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t KnowAndreea Maria Ursaru0Antoniu Octavian Petris1Irina Iuliana Costache2Ana Nicolae3Adrian Crisan4Nicolae Dan Tesloianu5Department of Cardiology, Emergency Clinical Hospital “Sf. Spiridon”, 700111 Iasi, RomaniaDepartment of Cardiology, Emergency Clinical Hospital “Sf. Spiridon”, 700111 Iasi, RomaniaDepartment of Cardiology, Emergency Clinical Hospital “Sf. Spiridon”, 700111 Iasi, RomaniaDepartment of Cardiology, Emergency Clinical Hospital “Sf. Spiridon”, 700111 Iasi, RomaniaDepartment of Cardiology, Emergency Clinical Hospital “Sf. Spiridon”, 700111 Iasi, RomaniaDepartment of Cardiology, Emergency Clinical Hospital “Sf. Spiridon”, 700111 Iasi, RomaniaImplantable cardioverter defibrillators (ICDs) are the cornerstone of primary and secondary prevention of sudden cardiac death (SCD) all around the globe. In almost 40 years of technological advances and multiple clinical trials, there has been a continuous increase in the implantation rate. The purpose of this review is to highlight the grey areas related to actual ICD recommendations, focusing specifically on the primary prevention of SCD. We will discuss the still-existing controversies strongly reflected in the differences between the international guidelines regarding ICD indication class in non-ischemic cardiomyopathy, and also address the question of early implantation after myocardial infarction in the absence of clear protocols for patients at high risk of life-threatening arrhythmias. Correlating the insufficient data in the literature for 40-day waiting times with the increased risk of SCD in the first month after myocardial infarction, we review the pros and cons of early ICD implantation.https://www.mdpi.com/2308-3425/9/4/120implantable cardioverter defibrillatorprimary preventionsecondary preventionischemic cardiomyopathynon-ischemic cardiomyopathyearly ICD implantation |
| spellingShingle | Andreea Maria Ursaru Antoniu Octavian Petris Irina Iuliana Costache Ana Nicolae Adrian Crisan Nicolae Dan Tesloianu Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know Journal of Cardiovascular Development and Disease implantable cardioverter defibrillator primary prevention secondary prevention ischemic cardiomyopathy non-ischemic cardiomyopathy early ICD implantation |
| title | Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know |
| title_full | Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know |
| title_fullStr | Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know |
| title_full_unstemmed | Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know |
| title_short | Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know |
| title_sort | implantable cardioverter defibrillator in primary and secondary prevention of scd what we still don t know |
| topic | implantable cardioverter defibrillator primary prevention secondary prevention ischemic cardiomyopathy non-ischemic cardiomyopathy early ICD implantation |
| url | https://www.mdpi.com/2308-3425/9/4/120 |
| work_keys_str_mv | AT andreeamariaursaru implantablecardioverterdefibrillatorinprimaryandsecondarypreventionofscdwhatwestilldontknow AT antoniuoctavianpetris implantablecardioverterdefibrillatorinprimaryandsecondarypreventionofscdwhatwestilldontknow AT irinaiulianacostache implantablecardioverterdefibrillatorinprimaryandsecondarypreventionofscdwhatwestilldontknow AT ananicolae implantablecardioverterdefibrillatorinprimaryandsecondarypreventionofscdwhatwestilldontknow AT adriancrisan implantablecardioverterdefibrillatorinprimaryandsecondarypreventionofscdwhatwestilldontknow AT nicolaedantesloianu implantablecardioverterdefibrillatorinprimaryandsecondarypreventionofscdwhatwestilldontknow |